For research use only. Not for therapeutic Use.
VPC-80051 racemate(Cat No.:I038114)is a small-molecule inhibitor developed to target the steroidogenic enzyme cytochrome P450 17A1 (CYP17A1), which plays a critical role in androgen biosynthesis. By inhibiting both 17α-hydroxylase and 17,20-lyase activities of CYP17A1, VPC-80051 effectively reduces androgen production, making it a potential therapeutic agent for androgen-dependent diseases such as prostate cancer. The racemic form contains a mixture of enantiomers, which may exhibit differing pharmacokinetic and pharmacodynamic properties. Preclinical studies suggest VPC-80051 racemate may offer improved efficacy and safety profiles compared to existing CYP17A1 inhibitors in hormone-driven cancers.
CAS Number | 877969-69-2 |
Synonyms | N-[1-(3,4-difluorophenyl)ethyl]-1H-indazole-3-carboxamide |
Molecular Formula | C16H13F2N3O |
Purity | ≥95% |
IUPAC Name | N-[(1S)-1-(3,4-difluorophenyl)ethyl]-1H-indazole-3-carboxamide |
InChI | InChI=1S/C16H13F2N3O/c1-9(10-6-7-12(17)13(18)8-10)19-16(22)15-11-4-2-3-5-14(11)20-21-15/h2-9H,1H3,(H,19,22)(H,20,21)/t9-/m0/s1 |
InChIKey | MVHNHGGJTMFAQP-VIFPVBQESA-N |
SMILES | C[C@@H](C1=CC(=C(C=C1)F)F)NC(=O)C2=NNC3=CC=CC=C32 |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |